TEVA stock on watch after EU approval for biosimilar to Roche’s Lucentis (NYSE:TEVA)
Teva Pharmaceutical Industries Ltd (TEVA) announced Monday that the European Commission authorized Ranivisio (ranibizumab), a biosimilar to Roche’s (RHHBY) (RHHBF) blockbuster eye…
TEVA stock on watch after EU approval for biosimilar to Roche’s Lucentis (NYSE:TEVA)
Teva Pharmaceutical Industries Ltd (TEVA) announced Monday that the European Commission authorized Ranivisio (ranibizumab), a biosimilar to Roche’s (RHHBY) (RHHBF) blockbuster eye…